Cargando…

Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream

BACKGROUND: The objective of this study was to identify the molecular processes responsible for the anti-lesional activity of imiquimod in subjects with actinic keratosis using global gene expression profiling. METHODS: A double-blind, placebo-controlled, randomized study was conducted to evaluate g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torres, Abel, Storey, Leslie, Anders, Makala, Miller, Richard L, Bulbulian, Barbara J, Jin, Jizhong, Raghavan, Shalini, Lee, James, Slade, Herbert B, Birmachu, Woubalem
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1796543/ https://www.ncbi.nlm.nih.gov/pubmed/17257431 http://dx.doi.org/10.1186/1479-5876-5-7

Ejemplares similares

Lichenoid keratosis successfully treated with topical imiquimod
por: BinJadeed, Hessah, et al.
Publicado: (2020)

Visualization and Treatment of Subclinical Actinic Keratoses with Topical Imiquimod 5% Cream: An Observational Study
por: Kopera, Daisy, et al.
Publicado: (2014)

Treatment of Cutaneous Tumors with Topical 5% Imiquimod Cream
por: Alessi, Sabrina Sisto, et al.
Publicado: (2009)

Earliest stage treatment of actinic keratosis with imiquimod 3.75% cream: Two case reports—Perspective for non melanoma skin cancer prevention
por: Kopera, Daisy
Publicado: (2020)

Imiquimod (Aldara cream).
por: Buck, H W
Publicado: (1998)

Real-World Experience With Topical 5-Fluorouracil 4% (40 mg/g) Cream for the Treatment of Actinic Keratosis
por: Briatico, Giulia, et al.
Publicado: (2023)

Disseminated Superficial Actinic Porokeratosis on the Face Treated with Imiquimod 5% Cream
por: Riad, Hassan, et al.
Publicado: (2013)

Cutaneus cancers in elderly Medical treatment of actinic keratosis and superficial coutaneus cancers: imiquimod
por: Dastoli, M N
Publicado: (2010)

Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists
por: Birmachu, Woubalem, et al.
Publicado: (2007)

Non-adherence to topical treatments for actinic keratosis
por: Shergill, Bav, et al.
Publicado: (2013)

Inverted follicular keratosis successfully treated with imiquimod
por: Karadag, Ayse Serap, et al.
Publicado: (2016)

Kaposi's sarcoma responding to topical imiquimod 5% cream: a case report
por: Benomar, Sophia, et al.
Publicado: (2009)

Evaluating the Efficacy and Safety of 4% 5-Fluorouracil Cream in Patients with Actinic Keratosis: An Expert Opinion
por: STOCKFLETH, Eggert, et al.
Publicado: (2023)

Effective Combination of Photodynamic Therapy and Imiquimod 5% Cream in the Treatment of Actinic Keratoses: Three Cases
por: Held, Laura, et al.
Publicado: (2013)

Facial Basal Cell Carcinoma Treated with Topical 5% Imiquimod Cream with Dermoscopic Evaluation
por: Singal, Archana, et al.
Publicado: (2016)

Cost-efficacy analysis of 3% diclofenac sodium, ingenol mebutate, and 3.75% imiquimod in the treatment of actinic keratosis
por: Nisticò, Steven, et al.
Publicado: (2018)

Ingenol mebutate: A novel topical drug for actinic keratosis
por: Aditya, Suruchi, et al.
Publicado: (2013)

Successful treatment of a keratoacanthoma in a young patient with the application of topical 5% imiquimod cream
por: Plachouri, Kerasia‐Maria, et al.
Publicado: (2021)

Imiquimod 3.75% for field‐directed therapy of actinic keratosis: results of a prospective case‐series study in Greece
por: Befon, Angeliki, et al.
Publicado: (2019)

Topical Diclofenac Reprograms Metabolism and Immune Cell Infiltration in Actinic Keratosis
por: Singer, Katrin, et al.
Publicado: (2019)

Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment
por: Azin, Marjan, et al.
Publicado: (2022)

Topical Treatments for Basal Cell Carcinoma and Actinic Keratosis in the United States
por: Tan, Isabella J., et al.
Publicado: (2023)

Safety, efficacy, and patient acceptability of imiquimod for topical treatment of actinic keratoses
por: Caperton, Caroline, et al.
Publicado: (2011)

GENITAL VITILIGO FOLLOWING USE OF IMIQUIMOD 5% CREAM
por: Zhang, Ruzhi, et al.
Publicado: (2011)

Prevention of airway inflammation with topical cream containing imiquimod and small interfering RNA for natriuretic peptide receptor
por: Wang, Xiaoqin, et al.
Publicado: (2008)

Topical Zinc Sulphate (25%) Solution: A New Therapy for Actinic Keratosis
por: Sharquie, Khalifa E., et al.
Publicado: (2012)

Patient‐reported outcomes of topical therapies in actinic keratosis: A systematic review
por: Grada, Ayman, et al.
Publicado: (2021)

A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies
por: Sinclair, Robert, et al.
Publicado: (2020)

Actinic Keratosis: Rationale and Management
por: Dodds, Annabel, et al.
Publicado: (2014)

Optimal treatment of actinic keratosis
por: Goldenberg, Gary
Publicado: (2013)

Virtual consultation for actinic keratosis
por: Dhariwal, Sukhjit, et al.
Publicado: (2020)

The Genomic Landscape of Actinic Keratosis
por: Thomson, Jason, et al.
Publicado: (2021)

Successful Treatment of Giant Basal Cell Carcinoma with Topical Imiquimod 5% Cream with Long Term Follow-up
por: Chun-Guang, M, et al.
Publicado: (2014)

Treatment of melanoma in-transit metastases with combination intralesional interleukin-2, topical imiquimod, and tretinoin 0.1% cream
por: Leventhal, Jonathan S., et al.
Publicado: (2016)

Treatment of Keratoacanthoma with 5% Imiquimod Cream and Review of the Previous Report
por: Jeon, Hye Chan, et al.
Publicado: (2011)

Pigmented Actinic Keratosis: Case Report and Review of an Uncommon Actinic Keratosis Variant that can Mimic Melanoma
por: Abudu, Boya, et al.
Publicado: (2019)

A consensus approach to improving patient adherence and persistence with topical treatment for actinic keratosis
por: Stockfleth, Eggert, et al.
Publicado: (2015)

Topical Photodynamic Therapy with Different Forms of 5-Aminolevulinic Acid in the Treatment of Actinic Keratosis
por: Bartosińska, Joanna, et al.
Publicado: (2022)

Topical Treatment of Actinic Keratosis and Metalloproteinase Expression: A Clinico-Pathological Retrospective Study
por: Campione, Elena, et al.
Publicado: (2022)

Refusal of Retreatment With Topical 5-Fluorouracil Among Patients With Actinic Keratosis: Qualitative Analysis
por: Singh, Rohan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6g6jgpounhviidjal54jmcp2b9